The epidemiology of Neisseria meningitidis meningitis in Togo during 2003-2005

Vaccine

Volumn 25, Issue SUPPL. 1, 2007, Pages

  Adjogble, Kokou Louis Sewonou ^a   Lourd, Mathilde ^b   Njanpop Lafourcade, Berthe Marie ^b   Traoré, Yves ^c   Hlomaschi, Avoko Fidelia Sitti ^a   Amegatse, K Agbenon ^d   Agbenoko, Kodjo ^d   Sanou, Oumarou ^e   Sita, Kroman ^b   Mueller, Judith E ^b   Gessner, Bradford D ^b  

^a MINISTÈRE DE LA SANTÉ   (Togo)

^b Agence de Medecine Preventive   (France)

^c UNIVERSITÉ DE OUAGADOUGOU   (Burkina Faso)

^d Ministère de la Sante Publique ^*  (Togo)

^e CENTRE MURAZ   (Burkina Faso)

Author keywords

Epidemiology; Meningitis; Meningococcus; Neisseria meningitidis; Serogroup; Togo

Indexed keywords

ADOLESCENT; ADULT; ANALYTIC METHOD; ARTICLE; BLOOD GROUP TYPING; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; EPIDEMIC MENINGITIS; GEOGRAPHY; HEALTH SURVEY; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; TOGO;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; GEOGRAPHY; HUMANS; MENINGITIS, MENINGOCOCCAL; NEISSERIA MENINGITIDIS; NEISSERIA MENINGITIDIS, SEROGROUP W-135; POLYMERASE CHAIN REACTION; SEASONS; TOGO;

EID: 34547662140     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.04.040     Document Type: Article

References (20)

1. Moore P.S. Meningococcal meningitis in sub-Saharan Africa: a model for the epidemic process. Clin Infect Dis 14 (1992) 515-525
2. Parent du Chatelet I., Traore Y., Gessner B.D., Antignac A., Naccro B., Njanpop-Lafourcade B.M., et al. Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing. Clin Infect Dis 40 (2005) 17-25
3. Decosas J., and Koama J.B.T. Chronicle of an outbreak foretold: meningococcal meningitidis W135 in Burkina Faso. Lancet 2 (2002) 763-765
4. Taha M.K., Parent Du Chatelet I., Schlumberger M., Sanou I., Djibo S., de Chabalier F., et al. Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger. J Clin Microbiol 40 (2002) 1083-1084
5. WHO. Epidemic meningitis: surveillance and response activities during the 2002-2003 season in the countries of the African meningitis belt. Report on an informal WHO consultation. WHO, Geneva 24-25 2003. WHO/CDS/CSR/GAR/2003.13; 2003.
6. Forgor A.A., Leimkugel J., Hodgson A., Bugri A., Dangy J.P., Gagneux, et al. Emergence of W135 meningococcal meningitis in Ghana. Trop Med Int Health 10 (2005) 1229-1234
7. Boisier P., Djibo S., Sidikou F., Mindadou H., Kairo K.K., Djibo, et al. Epidemiological patterns of meningococcal meningitis in Niger in 2003 and 2004: under the threat of N. meningitidis serogroup W135. Trop Med Int Health 10 (2005) 435-443
8. WHO. Enhanced surveillance of epidemic meningococcal meningitis in Africa: a three-year experience. Wkly Epidemiol Rep 37 (2005) 313-320
9. WHO. Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. WHO communicable disease surveillance and response. WHO/CDS/CSR/EDC/99.7, 1999.
10. Taha M.K. Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis. J Clin Microbiol 38 (2000) 855-857
11. Deghmane A.E., Giogini D., Larribe M., Alonso J.M., and Taha M.K. Down regulation of pili and capsule of Neisseria meningitidis upon contact with epithelial cells is mediated by CrgA regulatory protein. Mol Microbiol 43 (2002) 1555-1564
12. Corless C.E., Guiver M., Borrow R., Edwards-Jones V., Fox A.J., and Kaczmarski E.B. Simultaneous detection of Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae in suspected cases of meningitis and septicemia using real-time PCR. J Clin Microbiol 39 (2001) 1553-1558
13. Hassan-King M., Baldeh I., Adegbola R., Omosigho C., Usen S.O., Oparaugo A., et al. Detection of Haemophilus influenzae and Streptococcus pneumoniae DNA in blood culture by a single PCR assay. J Clin Microbiol 34 (1996) 2030-2032
14. Sidikou F., Djibo S., Taha M.K., Alonso J.M., Djibo A., Kairo K.K., et al. Polymerase chain reaction assay and bacterial meningitis surveillance in remote areas. Niger Emerg Infect Dis 9 (2003) 1486-1488
15. Greenwood B. Manson Lecture. Meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg 93 (1999) 341-353
16. Denis F., Rey J.L., Amadou A., Saliou P., Prince-David M., M'Boup S., et al. Emergence of meningococcal meningitis caused by W135 subgroup in Africa. Lancet 2 (1982) 1335-1336
17. Mayer L.W., Reeves M.W., Al-Hamdan N., Sacchi Ct., Taha Mk., Ajello G.W., et al. Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electrophoretic type 37 complex. J Infect Dis 185 (2002) 1596-1605
18. Taha M.K., Achtman M., Alonso J.M., Greenwood B., Ramsay M., Fox A., et al. Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet 356 (2000) 2159
19. Jodar L., LaForce F.M., Ceccarini C., Aguado T., and Granoff D.M. Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries. Lancet 361 (2003) 1902-1904
20. Djibo S., Nicolas P., Alonso J.M., Djibo A., Couret D., Riou J.Y., et al. Outbreaks of serogroup × meningococcal meningitis in Niger 1995-2000. Trop Med Int Health 8 (2003) 1118-1123